IRIS Accounts Production v25.4.0.155 13611241 director 1.10.24 30.9.25 30.9.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh136112412024-09-30136112412025-09-30136112412024-10-012025-09-30136112412023-09-30136112412023-10-012024-09-30136112412024-09-3013611241ns15:EnglandWales2024-10-012025-09-3013611241ns14:PoundSterling2024-10-012025-09-3013611241ns10:Director12024-10-012025-09-3013611241ns10:PrivateLimitedCompanyLtd2024-10-012025-09-3013611241ns10:SmallEntities2024-10-012025-09-3013611241ns10:AuditExempt-NoAccountantsReport2024-10-012025-09-3013611241ns10:SmallCompaniesRegimeForDirectorsReport2024-10-012025-09-3013611241ns10:SmallCompaniesRegimeForAccounts2024-10-012025-09-3013611241ns10:FullAccounts2024-10-012025-09-3013611241ns10:RegisteredOffice2024-10-012025-09-3013611241ns5:CurrentFinancialInstruments2025-09-3013611241ns5:CurrentFinancialInstruments2024-09-3013611241ns5:ShareCapital2025-09-3013611241ns5:ShareCapital2024-09-3013611241ns5:RetainedEarningsAccumulatedLosses2025-09-3013611241ns5:RetainedEarningsAccumulatedLosses2024-09-3013611241ns5:PlantMachinery2024-09-3013611241ns5:PlantMachinery2024-10-012025-09-3013611241ns5:PlantMachinery2025-09-3013611241ns5:PlantMachinery2024-09-3013611241ns5:WithinOneYearns5:CurrentFinancialInstruments2025-09-3013611241ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-30
REGISTERED NUMBER: 13611241 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 September 2025

for

CK Pharma Consultancy Ltd

CK Pharma Consultancy Ltd (Registered number: 13611241)






Contents of the Financial Statements
for the Year Ended 30 September 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


CK Pharma Consultancy Ltd

Company Information
for the Year Ended 30 September 2025







DIRECTOR: Ms T L C Kwok





REGISTERED OFFICE: The Coach House
1 Howard Road
Reigate
Surrey
RH2 7JE





REGISTERED NUMBER: 13611241 (England and Wales)





ACCOUNTANTS: ACL & Co
Chartered Certified Accountants
The Coach House
1 Howard Road
Reigate
RH2 7JE

CK Pharma Consultancy Ltd (Registered number: 13611241)

Balance Sheet
30 September 2025

30.9.25 30.9.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 61 82

CURRENT ASSETS
Debtors 5 - 4,237
Cash at bank 610,399 463,980
610,399 468,217
CREDITORS
Amounts falling due within one year 6 72,416 53,901
NET CURRENT ASSETS 537,983 414,316
TOTAL ASSETS LESS CURRENT
LIABILITIES

538,044

414,398

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 537,944 414,298
538,044 414,398

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

CK Pharma Consultancy Ltd (Registered number: 13611241)

Balance Sheet - continued
30 September 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 9 January 2026 and were signed by:





Ms T L C Kwok - Director


CK Pharma Consultancy Ltd (Registered number: 13611241)

Notes to the Financial Statements
for the Year Ended 30 September 2025

1. STATUTORY INFORMATION

CK Pharma Consultancy Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

CK Pharma Consultancy Ltd (Registered number: 13611241)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2025

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 October 2024
and 30 September 2025 196
DEPRECIATION
At 1 October 2024 114
Charge for year 21
At 30 September 2025 135
NET BOOK VALUE
At 30 September 2025 61
At 30 September 2024 82

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.25 30.9.24
£    £   
Other debtors - 4,237

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.25 30.9.24
£    £   
Tax 39,577 38,255
Social security and other taxes - 809
Other creditors 486 276
Directors' current accounts 31,124 13,541
Accrued expenses 1,229 1,020
72,416 53,901